http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006006617-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2005-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2006006617-A1 |
| titleOfInvention | Recovery promoter for dysfunction after onset of central nervous disease |
| abstract | A novel dysfunction recovery promoter or functional recovery training effect enhancement and / or promoter after the onset of a central nervous disease is provided. The present invention relates to a dysfunction recovery promoter after the onset of a central nervous disease containing, as an active ingredient, a compound that selectively and simultaneously enhances serotonin neurotransmission and norepinephrine neurotransmission, and serotonin neurotransmission and norepinephrine neurotransmission. The present invention relates to an agent for enhancing and / or promoting a function recovery training effect after the onset of a central nervous disease, which contains, as an active ingredient, a compound that selectively enhances each simultaneously. INDUSTRIAL APPLICABILITY The present invention is useful as providing an agent for promoting recovery of functional impairment after the onset of a central nervous disease and an agent for enhancing and / or promoting functional recovery training. In addition, the medicament of the present invention is useful as a safe drug having no anticholinergic action, drug dependence, or cardiovascular action causing side effects. |
| priorityDate | 2004-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.